Jones D N, Lew W, Wycherley A G
Department of Radiology, Flinders Medical Centre, Bedford Park, Australia.
Australas Radiol. 1994 Feb;38(1):61-3. doi: 10.1111/j.1440-1673.1994.tb00129.x.
This case report describes diffuse hepatic uptake of a diphosphonate bone scan agent (Technetium-99m-MDP) in a patient with amyloidosis associated with a plasma cell dyscrasia. Amyloid infiltration is one of the more rare, but well recognized, causes of hepatic uptake of bone scan tracer. Other causes are also discussed in this case report.
本病例报告描述了一名患有与浆细胞异常增生相关的淀粉样变性患者,双膦酸盐骨扫描剂(锝-99m-亚甲基二膦酸盐)在肝脏弥漫性摄取的情况。淀粉样变浸润是骨扫描示踪剂肝脏摄取较为罕见但已得到充分认识的原因之一。本病例报告还讨论了其他原因。